Publications by authors named "Athanasios Pseftogas"

Claim this Profile
L
Loss of CYLD promotes splenic marginal zone lymphoma.
Athanasios Pseftogas, Jessica Bordini, Silvia Heltai, Ferdinando Bonfiglio, Georgios Gavriilidis

Hemasphere· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
IκBε deficiency accelerates disease development in chronic lymphocytic leukemia.
Jessica Bordini, Chiara Lenzi, Michela Frenquelli, Alessia Morabito, Athanasios Pseftogas

Leukemia· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of the Tumor Suppressor CYLD Sensitizes Mice to Breast Cancer Development.
Athanasios Pseftogas, Konstantinos Xanthopoulos, Athanasios Siasiaridis, Theofilos Poutahidis, Christos Gonidas

Anticancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of Tumor Suppressor CYLD Inhibits Fibroblast Reprogramming to Pluripotency.
Nikolaos Bekas, Martina Samiotaki, Maria Papathanasiou, Panagiotis Mokos, Athanasios Pseftogas

Cancers (Basel)· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Tumor Suppressor CYLD Inhibits Mammary Epithelial to Mesenchymal Transition by the Coordinated Inhibition of YAP/TAZ and TGF Signaling.
Athanasios Pseftogas, Konstantinos Xanthopoulos, Theofilos Poutahidis, Chrysanthi Ainali, Dimitra Dafou

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HDAC1/2 Inhibitor Romidepsin Suppresses DEN-Induced Hepatocellular Carcinogenesis in Mice.
Hara Afaloniati, Katerina Angelopoulou, Alexander Giakoustidis, Alexandros Hardas, Athanasios Pseftogas

Onco Targets Ther· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Down-regulation of the Tumor Suppressor CYLD Enhances the Transformed Phenotype of Human Breast Cancer Cells.
Timoklia Orfanidou, Konstantinos Xanthopoulos, Dimitra Dafou, Athanasios Pseftogas, Paul Hadweh

Anticancer Res· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of peroxisome proliferator-activated receptor gamma in mammary epithelial cells upregulates the expression of tumor suppressor Cyld to mediate growth inhibition and anti-inflammatory effects.
Athanasios Pseftogas, Christos Gonidas, George Mosialos

Int J Biochem Cell Biol· January 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivation of CYLD in intestinal epithelial cells exacerbates colitis-associated colorectal carcinogenesis - a short report.
Demetrios N Karatzas, Konstantinos Xanthopoulos, Panorea Kotantaki, Athanasios Pseftogas, Konstantinos Teliousis

Cell Oncol (Dordr)· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis